Compounds > latrepirdine
Page last updated: 2024-09-05

latrepirdine and glutamic acid

latrepirdine has been researched along with glutamic acid in 2 studies

Compound Research Comparison

Studies
(latrepirdine)		Trials
(latrepirdine)		Recent Studies (post-2010)
(latrepirdine)		Studies
(glutamic acid)		Trials
(glutamic acid)		Recent Studies (post-2010) (glutamic acid)
12675941,75745212,876

Protein Interaction Comparison

ProteinTaxonomylatrepirdine (IC50)glutamic acid (IC50)
Chain A, GLUTAMATE RECEPTOR SUBUNIT 2Rattus norvegicus (Norway rat)0.821
Chain A, Glutamate Receptor Subunit 2Rattus norvegicus (Norway rat)0.821
Chain B, Glutamate Receptor Subunit 2Rattus norvegicus (Norway rat)0.821
Metabotropic glutamate receptor 8Homo sapiens (human)0.0057
Glutamate receptor ionotropic, NMDA 2DHomo sapiens (human)0.07
Glutamate receptor ionotropic, NMDA 3BHomo sapiens (human)0.07
Glutamate receptor 1Rattus norvegicus (Norway rat)0.5885
Glutamate receptor 2Rattus norvegicus (Norway rat)0.5885
Glutamate receptor 3Rattus norvegicus (Norway rat)0.5885
Glutamate receptor 4Rattus norvegicus (Norway rat)0.5885
Glutamate receptor ionotropic, kainate 1Rattus norvegicus (Norway rat)0.38
Glutamate receptor ionotropic, NMDA 1 Rattus norvegicus (Norway rat)0.1533
Glutamate receptor ionotropic, kainate 2Rattus norvegicus (Norway rat)0.38
Glutamate receptor 1Homo sapiens (human)0.613
Glutamate receptor 2Homo sapiens (human)0.613
Glutamate receptor 3Homo sapiens (human)0.613
Glutamate receptor ionotropic, kainate 3Rattus norvegicus (Norway rat)0.38
Excitatory amino acid transporter 1Homo sapiens (human)207
Glutamate receptor 4Homo sapiens (human)0.613
Glutamate receptor ionotropic, NMDA 2A Rattus norvegicus (Norway rat)0.1533
Glutamate receptor ionotropic, NMDA 2BRattus norvegicus (Norway rat)0.1533
Glutamate receptor ionotropic, NMDA 2CRattus norvegicus (Norway rat)0.1533
Glutamate receptor ionotropic, kainate 4Rattus norvegicus (Norway rat)0.38
Glutamate receptor ionotropic, NMDA 1Homo sapiens (human)0.07
Glutamate receptor ionotropic, NMDA 2AHomo sapiens (human)0.07
Glutamate receptor ionotropic, NMDA 2BHomo sapiens (human)0.07
Glutamate receptor ionotropic, NMDA 2CHomo sapiens (human)0.07
Glutamate receptor ionotropic, NMDA 2DRattus norvegicus (Norway rat)0.1533
Glutamate receptor ionotropic, kainate 5Rattus norvegicus (Norway rat)0.38
Glutamate receptor ionotropic, NMDA 3AHomo sapiens (human)0.07
Glutamate receptor ionotropic, NMDA 3BRattus norvegicus (Norway rat)0.1533
Glutamate receptor ionotropic, NMDA 3ARattus norvegicus (Norway rat)0.1533

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alvarez, SP; Anilkumar, U; Baumann, B; Bernas, T; Düssmann, H; Huber, HJ; Jordán, J; Kilbride, SM; Prehn, JH; Weisová, P1
Kuo, JR; Wang, CC; Wang, SJ1

Other Studies

2 other study(ies) available for latrepirdine and glutamic acid

ArticleYear
Latrepirdine is a potent activator of AMP-activated protein kinase and reduces neuronal excitability.
    Translational psychiatry, 2013, Oct-22, Volume: 3

    Topics: Adenosine Triphosphate; AMP-Activated Protein Kinases; Animals; Calcium-Calmodulin-Dependent Protein Kinase Kinase; Cerebellum; Gene Silencing; Glucose Transporter Type 3; Glutamic Acid; Indoles; Membrane Potentials; Mice; Mitochondria; Neocortex; Neurons; Neuroprotective Agents; Nootropic Agents; Protein Serine-Threonine Kinases; Rats

2013
Dimebon, an antihistamine drug, inhibits glutamate release in rat cerebrocortical nerve terminals.
    European journal of pharmacology, 2014, Jul-05, Volume: 734

    Topics: 4-Aminopyridine; Animals; Calcium; Calcium Channels, N-Type; Cerebral Cortex; Exocytosis; Glutamic Acid; Histamine Antagonists; Indoles; Male; Membrane Potentials; Neuroprotective Agents; Protein Kinase C; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Synaptosomes

2014